Xueying Liu
Hangzhou, 310000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A DNA Aptamer as a Chemical Tool to Modulate MEX3C-Mediated mRNA Destabilization.
Journal: ACS applied bio materials
Published: January 10, 2026
Energy Interception-Enhanced Ultrasound-Induced Luminescence Enables Efficient Anticancer Monitoring.
Journal: Angewandte Chemie (International ed. in English)
Published: August 14, 2025
PTf-SRiApt Targeting SCAF4-POLR2A Interaction Suppresses Tumor Growth and Promotes Antitumor Immunity in Triple-Negative Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 08, 2025
Dendrobium huoshanense flavone attenuates radiation enteritis by enhancing gut immunity to inhibit inflammation and fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 29, 2024
Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions.
Journal: Nature communications
Published: January 11, 2024
A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer.
Journal: Cell chemical biology
Published: November 27, 2023
Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.
Journal: Cancer
Published: September 20, 2023
Targeting TAF1 with BAY-299 induces antitumor immunity in triple-negative breast cancer.
Journal: Biochemical and biophysical research communications
Published: April 06, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026